Dr. Beena Bansal is a senior endocrinologist with a strong focus on advanced diabetes management and inpatient glycemic care. She is Director and Co-Founder of CareOps Solutions, where she designs “smart” insulin solutions to optimize glucose control in hospitalized patients, and Founder of Door to Care, a dedicated endocrine and diabetes clinic. She previously served as Director of Endocrinology at Medanta – The Medicity, Gurgaon.

Dr. Bansal completed her DM in Endocrinology from Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow. Her clinical expertise includes insulin therapy optimization, glycemic variability, diabetes in cardiac surgery, and hospital insulin protocols.

She has published widely in leading journals, including Diabetes Care, and has authored key textbook chapters on insulin therapy and glycemic emergencies. Her work bridges clinical research and practical implementation, improving safety and outcomes in diabetes care.

Dr. Joy Arabelle Fontanilla is a senior Consultant Endocrinologist with more than 25 years of clinical experience, with a strong focus on diabetes care, education, and metabolic health. She practices adult endocrinology at St. Luke's Medical Center–Global City and serves as Section Chief of Endocrinology, Diabetes & Metabolism at Asian Hospital & Medical Center.

Dr. Joy's clinical and research interests center on diabetes management, nutrition therapy, weight intervention, and cardiometabolic risk reduction. She leads the Center for Weight Intervention & Nutrition Services (WINS) and has been actively involved in advancing diabetes education, multidisciplinary care models, and evidence-based practice across the Philippines.

Board-certified in both the United States and the Philippines, Dr. Joy ranked in the top 10% of the American Board examinations in Internal Medicine and in Endocrinology, Diabetes & Metabolism. She has contributed extensively to diabetes research, national education initiatives, and professional guidelines, and remains deeply committed to improving outcomes for people living with diabetes.

Clinical Emeritus Professor Dr. Supawadee Likitmaskul is a Professor of Pediatrics and Associate Professor of Pediatric Endocrinology at the Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand, and is nationally recognized for her leadership and contributions to pediatric diabetes care and Diabetes Self‑Management Education and Support (DSMES).

She currently serves as Chair of the Siriraj Pediatric Diabetes Care Team, Head of the Siriraj Diabetes Center, roles she has held for more than a decade, Chair of the Certified Diabetes Educator Program at the Faculty of Medicine Siriraj Hospital, and Secretariat of the Thai Type 1 Diabetes and Diabetes Diagnosed Before Age 30 Years Registry, Care and Network (T1DDAR CN).

Professor Dr. Supawadee has devoted her career to improving the diagnosis, management, and long‑term outcomes of children and adolescents with diabetes. She has played a pivotal role in developing structured diabetes education programs, multidisciplinary care models, and diabetes camps aimed at strengthening self‑management skills and family engagement.

She is actively involved in regional and international diabetes initiatives and has served on committees of the Asia Pacific Pediatric Endocrine Society (APPES) and the International Diabetes Federation Western Pacific Region. Under her leadership, the Siriraj Diabetes Center achieved international recognition as an International Diabetes Federation (IDF) Center of Excellence, a status held since 2017.

Professor Dr. Supawadee is widely published in the field of pediatric diabetes and continues to contribute to advancing evidence‑based care and education for individuals living with diabetes.

Professor Emeritus Dr. Chan Siew Pheng is a highly distinguished Consultant Endocrinologist at Subang Jaya Medical Centre and a recognized leader in diabetes care and research. She holds the title of Professor Emeritus at the University of Malaya, where she obtained her medical degree, and is a Fellow of the Royal College of Physicians (Edinburgh).

Dr. Chan has extensive expertise in diabetes management and has played a key role in shaping national diabetes practice. She served as Chairperson of the 6th Malaysian Clinical Practice Guidelines for the Management of Type 2 Diabetes Mellitus, contributing to evidence-based diabetes care in Malaysia.

Dr. Chan's commitment to advancing medical knowledge is also evident through her active membership in international bodies like the Endocrine Society, USA, and her significant contributions to local organization such as the Malaysian Endocrine and Metabolic Society. Prof. Chan's academic work is widely published, reflecting her deep commitment to evidence-based medicine and regional leadership in metabolic health.

Ms. Uoon Jeong Shin is a Diabetes Education Nurse at the Diabetes Center of Asan Medical Center, where she has been dedicated to diabetes education and patient care since 2011. She began her nursing career at Asan Medical Center in 2007 and has developed extensive expertise in structured diabetes education, insulin therapy management, and chronic complication prevention.

She earned her Bachelor of Nursing from Kyungpook National University and a Master of Nursing from Ewha Womans University and is currently pursuing her doctoral degree in nursing at Yonsei University.

Her research interests include diabetes education and care transition for individuals with type 1 diabetes. She has published work on hypoglycemia risk factors, diabetic nephropathy self-care, and therapeutic nutrition, and contributed to the Korean Diabetes Association Diabetes Educator Guidelines (Blood Glucose Monitoring, 2020).

Ms. Shin is an active lecturer in national diabetes education programs and continuing nursing education, with a strong focus on safe insulin administration and advancing diabetes care practice.

Dr. Tri Juli Edi Tarigan is a Consultant Endocrinologist and Internist at the Division of Endocrinology and Metabolism, Faculty of Medicine, Universitas Indonesia, and Cipto Mangunkusumo National General Hospital, Jakarta.

With extensive clinical and academic experience, Dr. Tarigan specializes in comprehensive diabetes management, including insulin therapy optimization, management of hyperglycaemic crises, diabetic foot care, and prevention of chronic complications. He has played an active role in the development of national diabetes consensus statements and practical guidelines in Indonesia, contributing to improving standards of care across primary and specialist settings.

Dr. Tarigan is deeply committed to medical education and capacity building, frequently speaking at national and international scientific meetings on evidence-based diabetes care. His work focuses on translating clinical evidence into practical strategies that improve outcomes for people living with diabetes.

Dr. Sueziani Binte Zainudin is a Senior Consultant Endocrinologist & Director, Ascensus Health Specialist Centre – Ascensus Wellness with extensive experience in comprehensive diabetes and endocrine care. She previously served as Senior Consultant in Endocrinology at Sengkang General Hospital, where she helped pioneer integrated diabetes services.

Her clinical and research interests focus on integrated diabetes care, diabetes education, diabetes and Ramadan, and cardiometabolic risk management. She developed the internationally recognised DEAR (Diabetes Education and Medication Adjustment in Ramadan) programme and contributed to the IDF-DAR 2021 international guidelines.

An active researcher and educator, Dr. Sueziani has published widely in leading journals and remains committed to delivering evidence-based, culturally sensitive, and patient-centred diabetes care.

Dr. Saud Al Sifri currently holds the following positions at the Al Hada Armed Forces Hospitals, Taif, Saudi Arabia: Consultant Endocrinologist and Diabetologist, Director of the Diabetes and Endocrine Specialist Center, Director of Postgraduate Residency Training Programme and Chairman of the Endocrinology and Diabetes Department. He is also currently an Honorary Professor of Medicine & Endocrinology at Taif University.

After completing his Arab Board of Internal Medicine and Saudi Board in Internal Medicine, in 1998, Dr. Al Sifri joined the Fellowship programme of Endocrinology and Metabolism at King Faisal Specialist Hospital and Research Centre,Riyadh, and then Dr. Al Sifri pursued further research fellowships in 2001, at Western Ontario University, Canada and Fellowship of American College of Endocrinology Minnesota, USA. Finally, Dr. Al Ssifri has been awarded Fellowship of Royal College of Physician, UK.

Although Dr. Al Sifri has an active presence in committees within the Al Hada Armed Forces Hospital, he is also involved in many committees outside of the hospital. At present, this includes chairing the executive committee of the Saudi Society for Endocrinology & Metabolism, Taif and Vice-President of Saudi Diabetes Society. Dr. Al Sifri has been invited and delivered more than 200 lectures, presentations, and workshops nationally and internationally. He has written or contributed to over 100 research papers and has peer-reviewed for three international journals in the field of diabetes and endocrinology. Over the years, Dr. Al Sifri has received several honors and awards, including the International Donald Etzwiler Award for diabetes awareness and research in 2010.

Dr. Calliari is a Professor of Pediatric Endocrinology at Santa Casa de São Paulo School of Medical Sciences, and Coordinator of the Pediatric Diabetes Outpatient Clinic at Santa Casa de Misericordia of Sao Paulo. He has a master’s degree in Clinical Endocrinology at UNIFESP.

He is the founder and coordinator of the medical student's Diabetes League of FCMSCSP, and since 1990, he has been involved in the training of medical residents of Pediatric Endocrinology.

His major line of research is centered on childhood and adolescent diabetes, including a broad range of topics: the etiopathogenesis of type 1 diabetes, monogenic diabetes, cystic fibrosis–related diabetes and diabetes technology. He participated of national studies, as the BrazDiab1SG, the largest multicenter study on type 1 diabetes in Brazil, and the Brazilian MODY Network.

He is involved with the Brazilian Diabetes Society, where he is currently Advisor to the President, and Vice-President elect. He has been a member of the International Society for Pediatric and Adolescent Diabetes (ISPAD) since 2002 and was member of the Advisory Council (2015–2019), Executive Board (2018–2022). Currently, he Coordinator of the Special Interest Group in Diabetes in Schools, and the President-elect for the 2026 ISPAD Annual Conference in Rio de Janeiro.

Professor Liming Chen serves as the president of Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology of Tianjin Medical University and engaged in research, teaching, and clinical treatment. Prof. Chen focused on includes the mechanism of diabetes and its chronic complications. She is an Executive Board Member of IDF-WPR and the Chair-Elect of CDS.

El profesor Sandro Gentile es Profesor de Medicina Interna en la Universidad de Campania "Luigi Vanvitelli", en Nápoles, Italia. El profesor Gentile se especializa en Endocrinología y Enfermedades Metabólicas, Gastroenterología y Medicina Aeroespacial. El Prof. Gentile se desempeñó como Presidente de la Asociación Italiana de Diabetes (AMD) y de la Fundación AMD. Es Miembro Emérito del Comité de Árbitros de AMD y Ex Presidente de Nefrocenter Research. Actualmente, se desempeñan como Presidente de Nyx Research.

El Prof. Gentile ha publicado 365 artículos en revistas internacionales con 14,638 citas y ha escrito capítulos de monografías y materiales educativos en los campos del metabolismo, la nutrición y la diabetes. El Prof. Gentile ha realizado más de 100 presentaciones orales y pósters en congresos nacionales e internacionales, ha organizado varias conferencias de diabetología y ha sido director científico de diversos cursos educativos sobre diabetes y enfermedades metabólicas.

El Prof. Gentile es investigador principal de ensayos clínicos aleatorizados (RCT) nacionales e internacionales y actúa como revisor para múltiples revistas científicas. Son en los consejos editoriales de Terapia de la diabetes, Acta Diabetologica, Investigación y práctica clínica de la diabetes, Diabetología y Avances en la terapia. Actualmente coordina el Grupo de Estudio AMD-OSDI sobre Técnicas de Inyección Nacionales.

Dr. Lixin Guo is a Doctor of Medicine, Professor, and Chief Physician who serves as the Chief Expert of the Endocrinology Department at Beijing Hospital, National Geriatric Center. Dr. Guo is also a Doctoral Supervisor at both Peking University and Peking Union Medical College, in addition to serving as a Postdoctoral Advisor. Dr. Guo currently holds the position of Chairman of the Chinese Diabetes Society.

Dr. Guo's scientific expertise focuses on the pathogenesis and intervention of diabetic vascular disease, the role of biological rhythms in abnormal glucose and lipid metabolism, diabetes related comorbidities, and endocrine and metabolic disorders in the elderly.

Dr. Lutz Heinemann studied Process Engineering at the University of Applied Sciences, Düsseldorf, Germany, receiving his degree in 1976, and went on to study Biology at the University of Düsseldorf, qualifying as a Biologist in 1982. He worked 3 years as Assistant Professor in the Neurophysiology Department at Düsseldorf University. He went on to work with Professor M. Berger at the Clinic for Nutrition and Metabolism from 1985 to 1999. In 1999, he founded the Profil Institut für Stoffwechselforschung in Neuss, Germany. He was the CEO until 2009.

He is a member of national and international diabetes associations. He also sits on the Scientific Advisory Boards of various pharmaceutical and diagnostics companies. From 2011 until 2024 he was the Managing Editor of the Journal of Diabetes Science and Technology. His scientific research is focused on insulin pharmacology and diabetes technology. Between 2010 and 2015, he acted as coordinator for the EU-funded project AP@home.

Dr. Sanjay Kalra trained at the All-India Institute of Medical Sciences, New Delhi, India. Dr. Sanjay Kalra is an endocrinologist with two and a half decades of experience. Practicing at Karnal, India, he travels the world to teach, learn and share. As Past President of the South Asian Federation of Endocrine Societies (SAFES), Endocrine Society of India (ESI) and Indian Professional Association for Transgender Health (IPATH), he works to improve endocrine awareness and health across the globe. He continues these efforts in his current responsibility as Treasurer, International Society of Endocrinology (ISE), and Vice President, South Asian Obesity Forum.

This international leadership role embellishes his extensive editorial experience, gained in Diabetes Medicine (UK), Touch Reviews Endocrinology, Indian Journal of Endocrinology and Medicine (IJEM), Journal of Pakistan Medical Association (JPMA), and Indian Journal of Clinical Practice (IJCP) among others.

His h-index of 71 and i10 index of 450 bear testimony to his passion for medical writing. In his spare time, Sanjay enjoys dancing the bhangra, a Punjabi folk dance and exercising with the mugdar, the Indian club bell.

El Dr. David C. Klonoff es endocrinólogo especializado en el desarrollo y uso de tecnología para la diabetes. Es Director Médico del Instituto de Investigación en Diabetes Dorothy L. y James E. Frank del Centro Médico Mills-Peninsula en San Mateo, California, y Profesor Clínico de Medicina en la UCSF. Es el editor fundador del Journal of Diabetes Science and Technology El Dr. Klonoff recibió el premio al Médico Destacado de 2019 de la Asociación Americana de la Diabetes. Recibió el Premio Especial del Director de la FDA en 2010 por sus destacadas contribuciones relacionadas con la tecnología para la diabetes. Recibió también el IEEE Standards Association Conformity Assessment Award en 2022. El Dr. Klonoff ha sido elegido como Miembro del American College of Physicians, del Royal College of Physicians (Edimburgo), y del Instituto Americano de Ingeniería Médica y Biológica (AIMBE). Recibió el Discurso de la Medalla de Oro y el Premio al Científico Distinguido de 2012 del Centro de Especialidades en Diabetes de Dr. Mohan y la Fundación de Investigación sobre Diabetes de Madrás, en Chennai, India. El Dr. Klonoff es egresado de UC Berkeley, donde fue elegido para Phi Beta Kappa en su penúltimo año, y de la Escuela de Medicina de UCSF, donde fue elegido para Alpha Omega Alpha en su penúltimo año.  Su formación de posgrado en medicina interna y endocrinología incluyó dos años en el Hospital UCLA y tres años en los Hospitales UCSF. Presidió el Comité de Aseguramiento de Seguridad de Dispositivos Inalámbricos para Diabetes del IEEE 2621, ganador del premio SC, y presidió DTSeC y DTMoSt, los primeros y segundos estándares de ciberseguridad para dispositivos médicos consensuados en el mundo.

Dr. Ida Ayu Kshanti is a Consultant Physician and Endocrinologist in Jakarta, Indonesia, currently is the Chairman of The Indonesian Diabetes Educator Association (IDEA). She graduated with a medical degree and Internal Medicine Specialist from the Medical Faculty, Gajah Mada University in Yogyakarta, Indonesia and completed her education as an Endocrinologist from Medical Faculty, University of Indonesia in Jakarta, Indonesia. Dr. Ida Ayu Kshanti is a member of the Indonesian Society of Endocrinology. The last 16 years working in the field of endocrinology, especially in diabetes management, encompassed an overall and comprehensive management in diabetes including diabetes education outpatient and in patient clinic and diabetes foot clinic as well as teaching medical students and internal medicine residents. As her passion, she has dedicated 28 years to the IDEA. She has recently been elected as member of the Indonesian Medical College Council (MKKI) serving in the Accreditation and Certification Field. Dr. Ida Ayu Kshanti actively contributes to national and international conferences, publications and national guidelines in Diabetes and Diabetes Education.

Professor Yiming Li is a Standing Committee Member of the Chinese Diabetes Society (CDS). Head of the CDS Diabetic Neuropathy Group. Committee Member of the Endocrinology and Metabolism Physicians Branch of Chinese Medical Doctor Association. Additionally, he is the Vice Chair of the Shanghai Society of Endocrinology (Shanghai Medical Association), the Diabetes Branch of (Shanghai Association of Traditional Chinese Medicine), and the Endocrine and Metabolic Diseases Committee (Shanghai Society of Integrated Chinese and Western Medicine)

Prof. Li has undertaken 21 national medical research projects, including Major New Drug Development programs and major projects under the National Science and Technology Innovation 2030 initiatives; He has published over 120 SCI-indexed papers.

Prof. Li's main clinical and research interests include neuroendocrine diseases, diabetic neuropathy, and obesity-related insulin resistance.

Julia Mader is Full Professor of Diabetes Technology at Medical University of Graz and Deputy Head of the Diabetes Outpatient Clinic. She graduated at Medical University of Graz where she also trained in Internal Medicine and Endocrinology. She was Visiting Professor at the University Hospital of Bern, Switzerland (2016-2017). She leads the Diabetes Technology Research Unit at Medical University of Graz.

Her research focuses on diabetes technology (insulin pumps, continuous glucose monitoring, automated insulin delivery system, diabetes management in the hospital and decision support systems). She has published over 190 peer-reviewed scientific papers. She has received several national and international awards. She is honorary secretary and board member of the Austrian Diabetes Society and is executive board member of the EASD and chairs EASD's Training and Education Committee.

Dr. Vasquez is a Board-Certified Family Physician with a special interest in chronic diseases and skin disorders. He practices in Vancouver, British Columbia, Canada. As a Clinical Assistant Professor at the University of British Columbia College of Medicine, he mentors both undergraduate and postgraduate learners. He is an Executive Board Member of the Vancouver Division of Family Practice and a member of the Embecta Canada Advisory Board. He has been invited to sit on a number of industry advisory boards at both the local and national level for Primary Care insights when new and novel molecules are launched in Canada.

Professor Yong Mong Bee is an endocrinologist with over 20 years of experience. He is the Head and Senior Consultant of the Department of Endocrinology at the Singapore General Hospital (SGH). He also holds the position of Clinical Associate Professor at Duke-NUS Medical School, Singapore, and Director of the Data Science and Artificial Intelligence Laboratory at SGH.

Prof. Bee's clinical focus is primarily on the management of diabetes mellitus and prevention of cardiovascular-kidney complications. He leads research programs aimed at diabetes prevention, risk prediction for diabetic complications, and leveraging artificial intelligence in diabetes care. He was instrumental in establishing the SingHealth Diabetes Registry (SDR), a comprehensive multi-institutional database derived from the SingHealth Electronic Medical Record system. He was the Principal Investigator of the A*STAR-funded Diabetes Clinic of the Future (DCOF) program, which aimed to develop solutions using big data analytics and digital technology to personalize care and improve outcomes among the multi-ethnic diabetes population in Singapore.

In addition to his roles at SGH, Prof. Bee is the President of Diabetes Singapore, the sole registered charitable organization in Singapore devoted exclusively to the fight against diabetes.

Dr. Julia Blanchette is an Assistant Professor of Medicine at Case Western Reserve University. She is also a Nurse Scientist in the Division of Endocrinology, and a Certified Diabetes Care and Education Specialist, Board Certified in Advanced Diabetes Management at the University Hospitals Diabetes & Metabolic Care Center. She completed her Bachelor of Science in Nursing at the Frances Payne Bolton School of Nursing in 2014 and her PhD in Nursing Science in 2019, earning both at Case Western Reserve University. Dr Blanchette was the inaugural Association of Diabetes Care and Education Specialists (ADCES) and the Certification Board for Diabetes Care and Education (CBDCE) Post-Doctoral Fellow in Integrated Diabetes Management and trained at the University of Utah College of Nursing. She received the national Rising Diabetes Star Award from ADCES in 2019 and became a fellow of ADCES (FADCES) in 2025. She received the 2024 Behavioral Medicine and Psychology Early Career Award from the American Diabetes Association (ADA) and is on the editorial board for ADA's interdisciplinary healthcare journal, Diabetes, Obesity and Cardiometabolic CARE.

Dr. Blanchette is recognized for integrating community-engaged research, behavioral science, and lived experience to develop practical, patient-centered approaches to diabetes education and support. She is the Principal Investigator of the iHERO Study, a national RCT testing a financial and health insurance literacy intervention designed in partnership with the type 1 diabetes community and The Diabetes Link, funded by the Leona M. and Harry B. Helmsley Charitable Trust. Clinically, her work focuses on improving diabetes self-management outcomes among young adults with type 1 diabetes and during life transitions, and she is a diabetes technology expert.

Dr. Persis Commissariat is a licensed clinical psychologist and certified diabetes care and education specialist in the Joslin Diabetes Center’s Pediatric, Adolescent, and Young Adult Section as well as an Assistant Investigator in the Section on Clinical, Behavioral, & Outcomes Research. She is an Assistant Professor of Psychology at Harvard Medical School. Dr. Commissariat provides individual and family therapy to children, teens, and young adults with diabetes at Joslin, with special interests in adjustment to new diabetes diagnosis, coping skills, diabetes burnout, and treatment adherence challenges. Her research focuses on illness identity, diabetes technologies, qualitative methods, and behavior change. She is the Principal Investigator on a grant from the National Institutes of Health studying ways to improve diabetes technology engagement and health outcomes by promoting positive diabetes identities. Dr. Commissariat currently serves on leadership teams for the American Diabetes Association (ADA) Mental Health Advisory Group and the ADA Youth Strategies Committee. She previously served as an Advisor for the ADA Behavioral Medicine and Psychology Interest Group.

Dr. Gabbay is a Professor at Federal University of São Paulo, with a Postdoctoral degree in Clinical Endocrinology from the same institution. She is a coordinator of Diabetes Technology at the Diabetes Center at UNIFESP with more than 30 years of experience in Type 1 diabetes, and also a coordinator of Type 1 Diabetes of Youth at the Brazilian Diabetes Society. She is the Principal Investigator at IBTED and the Educational Director of G7Med.

Dr. Daphne Gardner graduated from Oxford University (UK) [BA (Physiological Sciences), BMBCh (Oxon)] and was a clinical lecturer in Plymouth (UK) before attaining specialist accreditation in Endocrinology in Singapore. Her fellowship year was spent in the Oxford Centre for Diabetes, Endocrinology and Metabolism, UK. She now serves as a Senior Consultant Endocrinologist and lead clinician for Young Adults with Diabetes, Monogenic diabetes and the Intensive Insulin programme (including pumps and CGM) in Singapore General Hospital. She is an Adjunct Associate Professor with Duke-NUS Graduate Medical School and Director of Education in the SingHealth-Duke Disease Centre for Diabetes. She has held 2 grants aimed at stratifying diabetes to direct personalised therapy, and a Ministry of Health (Singapore) grant in the use of flash glucose monitoring to enhance diabetes education in type 2 diabetes. She currently runs the Diabetes in Asians at Risk in Youth (DIARY), a study that aims to develop novel risk tools to detect those at highest risk of Asian young onset diabetes.

Dr. Sanjay Kalra trained at the All-India Institute of Medical Sciences, New Delhi, India. Dr. Sanjay Kalra is an endocrinologist with two and a half decades of experience. Practicing at Karnal, India, he travels the world to teach, learn and share. As Past President of the South Asian Federation of Endocrine Societies (SAFES), Endocrine Society of India (ESI) and Indian Professional Association for Transgender Health (IPATH), he works to improve endocrine awareness and health across the globe. He continues these efforts in his current responsibility as Treasurer, International Society of Endocrinology (ISE), and Vice President, South Asian Obesity Forum.

This international leadership role embellishes his extensive editorial experience, gained in Diabetes Medicine (UK), Touch Reviews Endocrinology, Indian Journal of Endocrinology and Medicine (IJEM), Journal of Pakistan Medical Association (JPMA), and Indian Journal of Clinical Practice (IJCP) among others.

His h-index of 71 and i10 index of 450 bear testimony to his passion for medical writing. In his spare time, Sanjay enjoys dancing the bhangra, a Punjabi folk dance and exercising with the mugdar, the Indian club bell.

Dr. Maahs is the Lucile Salter Packard Professor of Pediatrics at Stanford University where he is the Division Chief of Pediatric Endocrinology, Associate Chair for Academic Affairs in Pediatrics and Associate Dean for Academic Affairs in the School of Medicine. He is the Associate Director of the Stanford Diabetes Research Center and Past-President of the International Society of Pediatric and Adolescent Diabetes (ISPAD) and has served as Editor-in-Chief of the ISPAD Guidelines and on the ADA Professional Practice Committee.

Margaret Pellizzari, known to most as Peggy, is the Diabetes Program Manager for Pediatric Endocrinology at Cohen Children's Medical Center (CCMC), part of Northwell Health. Ms. Pellizzari coordinates diabetes care for the children, both inpatient and outpatient. She is the Past LI Advocacy Chair for the American Diabetes Association, teaching classes for families and professionals to ensure diabetes safety and wellness in the community. Ms. Pellizzari has participated as a research investigator for several diabetes studies. Peggy has served as the President of the Metropolitan NY Chapter of Diabetes Care and Education Specialists and the New York State Chair for the Association of Diabetes Education and Care Specialists. Ms. Pellizzari has published and co-authored several articles and abstracts presented at national conferences. Peggy serves in several leadership positions within Northwell Health. She is a board member of NYS ADCES and serves as a volunteer for the ADA Safe at School Working Group, Breakthrough Type 1 Diabetes, and the DRIF. On a personal level, Peggy has been living well with type 1 diabetes for over 48 years. Her passion is helping children, their families, and all individuals with diabetes live healthy and happy lives while managing diabetes. Her passions include gardening, bike riding, going to the beach, and belly dancing.

Dr. Jannet Svensson is at pediatric professor and diabetologist from Copenhagen, Denmark. She is team leader of the Pediatric and Technology research group at Steno Diabetes Center Copenhagen (SDCC) and chief physician in the pediatric and adolescent clinic at SDCC. She has special interest in diabetes technology, skin problems due to diabetes devices, sleep and exercise.

She is a member of the steering committee for the Danish Diabetes Database (DDiD), which encompasses all age groups and types of diabetes in Denmark. In 2008, she collaborated with Nordic colleagues to initiate NordicDiabKids, a successful joint effort among Nordic childhood diabetes registries. Currently, she is responsible for collecting incidence data for Eurodiab, member of SWEET advisory board and secretary general in the ISPAD executive board. Her extensive research portfolio includes the publication of over 150 papers, and her academic profiles can be found on ORCID (0000-0002-9365-0728) and Web of Science (AAI-9913-2021).

Caterina Conte, MD, Ph, is a Full Professor of Internal Medicine at San Raffaele Roma University in Rome and Head of the Obesity and Obesity-related Cardiometabolic Complications Research Unit and Obesity Clinic at IRCCS MultiMedica in Milan, Italy. She received her MD from Sapienza University of Rome, completed her residency in Internal Medicine in 2012, and earned a PhD in Experimental Endocrine and Endocrine-Surgical Sciences from the Catholic University of Rome in 2016. Her training includes a research fellowship at the Center for Human Nutrition, Washington University School of Medicine in St. Louis, Missouri.

Her work focuses on integrating clinical care and research to address obesity and its cardiometabolic complications, including type 2 diabetes and sarcopenic obesity. She is actively involved in national and international scientific societies, including the European Association for the Study of Diabetes (EASD), the European Federation of Internal Medicine, the Italian Society of Internal Medicine, and the Italian Society of Bariatric and Metabolic Surgery for Obesity. She contributes to academic education as a member of the EASD Training and Education Committee and as a member of the Executive Board of the Italian College of Academic Internal Medicine, with a focus on improving teaching, research, and clinical practice in Internal Medicine. She has published extensively in the field of obesity and metabolism and is a strong advocate for the recognition of obesity as a disease and for comprehensive strategies for its prevention and treatment.

Dr. Lutz Heinemann studied Process Engineering at the University of Applied Sciences, Düsseldorf, Germany, receiving his degree in 1976, and went on to study Biology at the University of Düsseldorf, qualifying as a Biologist in 1982. He worked 3 years as Assistant Professor in the Neurophysiology Department at Düsseldorf University. He went on to work with Professor M. Berger at the Clinic for Nutrition and Metabolism from 1985 to 1999. In 1999, he founded the Profil Institut für Stoffwechselforschung in Neuss, Germany. He was the CEO until 2009.

He is a member of national and international diabetes associations. He also sits on the Scientific Advisory Boards of various pharmaceutical and diagnostics companies. From 2011 until 2024 he was the Managing Editor of the Journal of Diabetes Science and Technology. His scientific research is focused on insulin pharmacology and diabetes technology. Between 2010 and 2015, he acted as coordinator for the EU-funded project AP@home.

El Dr. Akshay Jain es el primer médico canadiense en estar certificado por triple junta por los Consejos Estadounidenses en Endocrinología, Medicina Interna y Medicina de la Obesidad.

Se formó en Medicina Interna en Rochester, NY, donde se convirtió en el único ganador en 4 ocasiones de los prestigiosos Premios de la Academia de Medicina de Rochester. Completó su especialización en Endocrinología en Harbor UCLA/City of Hope en Los Ángeles, California.

Es el único médico no estadounidense en ganar el premio AACE Rising Star in Endocrinology (2022) y en aparecer en la lista de Medscape de las 25 Estrellas Emergentes de la Medicina (2020). Es el primer norteamericano en ganar la prestigiosa Beca Etzwiler de Diabetes en el International Diabetes Center y la Mayo Clinic en MN, EE. UU.

Es un educador reconocido y ha dado conferencias en más de 1000 eventos médicos alrededor del mundo hasta la fecha. Es redactor de preguntas para los exámenes de la American Board of Obesity Medicine así como para el Programa de Autoevaluación de la Sociedad Endocrina (ESAP). Es coautor del capítulo de las Guías de Diabetes Canadá 2023 sobre Salud Mental y Diabetes. También es copresidente de las Conferencias de Actualización en Obesidad y Actualización en Diabetes.

Sus intereses clínicos incluyen diabetes, obesidad, trastornos tiroideos y osteoporosis.

Tiene canales activos en YouTube/Instagram dedicados a la educación del paciente con miles de visualizaciones hasta la fecha.

Habla con fluidez 6 idiomas, incluyendo inglés, hindi, guyaratí, maratí, marwari y urdu. En 2022, ganó el premio Top 25 Canadian Immigrant Award, el premio Healthcare Achievement Award otorgado por Drishti Magazine, y también fue destacado en la lista de Emerging Leaders of Canada de The Peak en 2023.

Dr. Sanjay Kalra trained at the All-India Institute of Medical Sciences, New Delhi, India. Dr. Sanjay Kalra is an endocrinologist with two and a half decades of experience. Practicing at Karnal, India, he travels the world to teach, learn and share. As Past President of the South Asian Federation of Endocrine Societies (SAFES), Endocrine Society of India (ESI) and Indian Professional Association for Transgender Health (IPATH), he works to improve endocrine awareness and health across the globe. He continues these efforts in his current responsibility as Treasurer, International Society of Endocrinology (ISE), and Vice President, South Asian Obesity Forum.

This international leadership role embellishes his extensive editorial experience, gained in Diabetes Medicine (UK), Touch Reviews Endocrinology, Indian Journal of Endocrinology and Medicine (IJEM), Journal of Pakistan Medical Association (JPMA), and Indian Journal of Clinical Practice (IJCP) among others.

His h-index of 71 and i10 index of 450 bear testimony to his passion for medical writing. In his spare time, Sanjay enjoys dancing the bhangra, a Punjabi folk dance and exercising with the mugdar, the Indian club bell.

El Dr. David C. Klonoff es endocrinólogo especializado en el desarrollo y uso de tecnología para la diabetes. Es Director Médico del Instituto de Investigación en Diabetes Dorothy L. y James E. Frank del Centro Médico Mills-Peninsula en San Mateo, California, y Profesor Clínico de Medicina en la UCSF. Es el editor fundador del Journal of Diabetes Science and Technology El Dr. Klonoff recibió el premio al Médico Destacado de 2019 de la Asociación Americana de la Diabetes. Recibió el Premio Especial del Director de la FDA en 2010 por sus destacadas contribuciones relacionadas con la tecnología para la diabetes. Recibió también el IEEE Standards Association Conformity Assessment Award en 2022. El Dr. Klonoff ha sido elegido como Miembro del American College of Physicians, del Royal College of Physicians (Edimburgo), y del Instituto Americano de Ingeniería Médica y Biológica (AIMBE). Recibió el Discurso de la Medalla de Oro y el Premio al Científico Distinguido de 2012 del Centro de Especialidades en Diabetes de Dr. Mohan y la Fundación de Investigación sobre Diabetes de Madrás, en Chennai, India. El Dr. Klonoff es egresado de UC Berkeley, donde fue elegido para Phi Beta Kappa en su penúltimo año, y de la Escuela de Medicina de UCSF, donde fue elegido para Alpha Omega Alpha en su penúltimo año.  Su formación de posgrado en medicina interna y endocrinología incluyó dos años en el Hospital UCLA y tres años en los Hospitales UCSF. Presidió el Comité de Aseguramiento de Seguridad de Dispositivos Inalámbricos para Diabetes del IEEE 2621, ganador del premio SC, y presidió DTSeC y DTMoSt, los primeros y segundos estándares de ciberseguridad para dispositivos médicos consensuados en el mundo.

Dr. Xiaomu Li is a Professor and Chief Physician specializing in endocrinology and metabolic diseases. She currently serves as Deputy Director of the Department of Endocrinology and Metabolic Disease at The First Affiliated Hospital, College of Medicine, Zhejiang University in Hangzhou, China. Her clinical and research expertise focuses on pancreatic beta cell physiology, diabetes pathophysiology, and the metabolic mechanisms underlying insulin secretion and beta cell dysfunction. Dr. Li has held several leadership roles, including Vice Chair of the Shanghai Diabetes Society and the Youth Committee of the Chinese Diabetes Society. Dr. Li has authored numerous publications surrounding mitochondrial metabolism, beta cell senescence, and diabetes associated with pancreatic disease.

Julia Mader is Full Professor of Diabetes Technology at Medical University of Graz and Deputy Head of the Diabetes Outpatient Clinic. She graduated at Medical University of Graz where she also trained in Internal Medicine and Endocrinology. She was Visiting Professor at the University Hospital of Bern, Switzerland (2016-2017). She leads the Diabetes Technology Research Unit at Medical University of Graz.

Her research focuses on diabetes technology (insulin pumps, continuous glucose monitoring, automated insulin delivery system, diabetes management in the hospital and decision support systems). She has published over 190 peer-reviewed scientific papers. She has received several national and international awards. She is honorary secretary and board member of the Austrian Diabetes Society and is executive board member of the EASD and chairs EASD's Training and Education Committee.

La Dra. Eden Miller, médica osteópata certificada en medicina familiar, obtuvo su título en la Facultad de Medicina Osteopática de Kirksville en 1997. Al regresar al noroeste, completó su residencia en Medicina Familiar en el Hospital East Moreland en Portland, Oregón. Tras completar recientemente su certificación en el manejo de la obesidad, fundó Diabetes Nation, una organización sin fines de lucro, y se convirtió en directora ejecutiva de Diabetes and Obesity Care LLC, donde ejerce junto a su esposo, el Dr. Kevin Miller, en Bend.

La Dra. Miller ha desarrollado un interés especial en la diabetes, después de haber contraído diabetes tipo 1 mientras cursaba la facultad de medicina. A partir de esa experiencia personal, su práctica se ha extendido hacia una subespecialidad en el cuidado de la diabetes. Oradora apasionada, la Dra. Miller ha impartido más de 1250 conferencias en el campo de la diabetes a profesionales de la salud y pacientes por igual, sobre temas como el manejo de la diabetes, tecnología de monitoreo continuo de glucosa (CGM), terapia con bomba de insulina, intervención en obesidad y metabolismo, investigación clínica y políticas de salud. Su lema para la atención médica es que “solo tiene éxito como profesional si convierte a los pacientes en expertos en su propia enfermedad”.

La Dra. Miller cree que un “enfoque individualizado fisiológico del paciente con diabetes” es fundamental para el éxito. Ella considera que, para que nuestra nación supere los estragos de la diabetes, se necesita un esfuerzo colaborativo, sin miedo al escrutinio personal ni barreras para un tratamiento eficaz, las cuales deben eliminarse.

André Gustavo Daher Vianna, MD, PhD, is a board-certified endocrinologist with extensive clinical, academic, and research experience in diabetes and metabolic diseases. He earned his medical degree from the Federal University of Paraná (UFPR), Brazil, followed by residency training in Internal Medicine at HC-UFPR and specialization in Endocrinology at Hospital Brigadeiro (SUS-SP). He holds a PhD in Health Sciences from PUC-PR.

Dr. Vianna is currently Vice-President of the Brazilian Diabetes Society (2026–2027) and has previously held several leadership roles within the Society. He is an active contributor to national initiatives in digital health and novel diabetes therapies.

He serves as Executive Director and Clinical Researcher at the Curitiba Diabetes Center, where he also coordinates the New Technologies Unit, focusing on innovations in diabetes care, continuous glucose monitoring, and insulin delivery systems. He is also a preceptor in the Endocrinology specialization program at Hospital Nossa Senhora das Graças.

Dr. Vianna has authored and co-authored multiple scientific publications in the fields of insulin therapy, type 2 diabetes management, and diabetes technologies. He is a frequent speaker and consultant on emerging treatments and technologies for diabetes, obesity, and endocrine disorders, and an active member of international scientific societies.